Dynavax — Pharmacodynamic changes confirm the mechanism of action mediating SD-101 efficacy, in combination with pembrolizumab, in a phase 1b/2 study in metastatic melanoma

 In Poster/Presentation
Recent Posts
0

Start typing and press Enter to search